AMERICAN HEALTHCARE REIT INC (AHR) Fundamental Analysis & Valuation

NYSE:AHR • US3981823038

Current stock price

47.13 USD
-0.28 (-0.59%)
At close:
47.13 USD
0 (0%)
After Hours:

This AHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AHR Profitability Analysis

1.1 Basic Checks

  • In the past year AHR was profitable.
  • In the past year AHR had a positive cash flow from operations.
  • In multiple years AHR reported negative net income over the last 5 years.
  • In the past 5 years AHR always reported a positive cash flow from operatings.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.23%, AHR is in line with its industry, outperforming 40.65% of the companies in the same industry.
  • AHR has a Return On Equity (-0.95%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.05%, AHR is in line with its industry, outperforming 57.72% of the companies in the same industry.
  • AHR had an Average Return On Invested Capital over the past 3 years of 2.69%. This is in line with the industry average of 3.11%.
  • The 3 year average ROIC (2.69%) for AHR is below the current ROIC(3.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROIC 3.05%
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • AHR's Operating Margin of 28.52% is in line compared to the rest of the industry. AHR outperforms 58.54% of its industry peers.
  • In the last couple of years the Operating Margin of AHR has grown nicely.
  • The Gross Margin of AHR (67.74%) is comparable to the rest of the industry.
  • AHR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.52%
PM (TTM) N/A
GM 67.74%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AHR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AHR is destroying value.
  • Compared to 1 year ago, AHR has more shares outstanding
  • The number of shares outstanding for AHR has been increased compared to 5 years ago.
  • AHR has a worse debt/assets ratio than last year.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • AHR has an Altman-Z score of 1.39. This is a bad value and indicates that AHR is not financially healthy and even has some risk of bankruptcy.
  • With an excellent Altman-Z score value of 1.39, AHR belongs to the best of the industry, outperforming 88.62% of the companies in the same industry.
  • A Debt/Equity ratio of 1.91 is on the high side and indicates that AHR has dependencies on debt financing.
  • AHR's Debt to Equity ratio of 1.91 is on the low side compared to the rest of the industry. AHR is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACC0.39
WACC7.84%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 0.24 indicates that AHR may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.24, AHR is doing worse than 86.99% of the companies in the same industry.
  • AHR has a Quick Ratio of 0.24. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.23, AHR is doing worse than 83.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.23
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AHR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 11.76% over the past year.
  • AHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -59.74%.
  • The Revenue has been decreasing by -5.76% on average over the past years.
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.28% on average over the next years. This is a very strong growth
  • AHR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 78.98% yearly.
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AHR Valuation Analysis

4.1 Price/Earnings Ratio

  • AHR is valuated quite expensively with a Price/Earnings ratio of 124.03.
  • AHR's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 24.89, AHR is valued quite expensively.
  • The Price/Forward Earnings ratio is 385.05, which means the current valuation is very expensive for AHR.
  • AHR's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, AHR is valued quite expensively.
Industry RankSector Rank
PE 124.03
Fwd PE 385.05
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • AHR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AHR is more expensive than 91.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.36
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AHR's earnings are expected to grow with 44.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.45%
EPS Next 3Y44.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. AHR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.11%, AHR has a reasonable but not impressive dividend return.
  • With a Dividend Yield of 2.11, AHR pays less dividend than the industry average, which is at 7.54. 85.37% of the companies listed in the same industry pay a better dividend than AHR!
  • AHR's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

  • AHR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • AHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1265.55%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

AHR Fundamentals: All Metrics, Ratios and Statistics

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (3/27/2026, 8:04:00 PM)

After market: 47.13 0 (0%)

47.13

-0.28 (-0.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-16
Earnings (Next)05-05
Inst Owners78.11%
Inst Owner Change15.14%
Ins Owners0.63%
Ins Owner Change-1.94%
Market Cap4.89B
Revenue(TTM)285.20M
Net Income(TTM)-5.94M
Analysts80
Price Target59.24 (25.69%)
Short Float %11.87%
Short Ratio7.63
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-1265.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)211.82%
Min EPS beat(2)-187.15%
Max EPS beat(2)610.78%
EPS beat(4)2
Avg EPS beat(4)120.69%
Min EPS beat(4)-345.1%
Max EPS beat(4)610.78%
EPS beat(8)4
Avg EPS beat(8)192.99%
EPS beat(12)5
Avg EPS beat(12)80.89%
EPS beat(16)9
Avg EPS beat(16)93.59%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.58%
Max Revenue beat(2)2.79%
Revenue beat(4)4
Avg Revenue beat(4)366.94%
Min Revenue beat(4)0.58%
Max Revenue beat(4)738.85%
Revenue beat(8)8
Avg Revenue beat(8)532.61%
Revenue beat(12)12
Avg Revenue beat(12)450.59%
Revenue beat(16)16
Avg Revenue beat(16)365.86%
PT rev (1m)3.57%
PT rev (3m)3.55%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-83.26%
EPS NY rev (3m)-83.31%
Revenue NQ rev (1m)-89.02%
Revenue NQ rev (3m)-88.56%
Revenue NY rev (1m)-88.61%
Revenue NY rev (3m)-88.33%
Valuation
Industry RankSector Rank
PE 124.03
Fwd PE 385.05
P/S 17.13
P/FCF N/A
P/OCF 76.06
P/B 7.78
P/tB 8.88
EV/EBITDA 37.36
EPS(TTM)0.38
EY0.81%
EPS(NY)0.12
Fwd EY0.26%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.62
OCFY1.31%
SpS2.75
BVpS6.05
TBVpS5.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.2
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROCE 3.86%
ROIC 3.05%
ROICexc 3.13%
ROICexgc 3.34%
OM 28.52%
PM (TTM) N/A
GM 67.74%
FCFM N/A
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
ROICexc(3y)2.76%
ROICexc(5y)2.56%
ROICexgc(3y)2.95%
ROICexgc(5y)2.74%
ROCE(3y)3.4%
ROCE(5y)3.17%
ROICexgc growth 3Y6.79%
ROICexgc growth 5Y8.56%
ROICexc growth 3Y7.57%
ROICexc growth 5Y8.47%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Debt/EBITDA 6.94
Cap/Depr 98.96%
Cap/Sales 31.75%
Interest Coverage 1.11
Cash Conversion 37.18%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.23
Altman-Z 1.39
F-Score5
WACC7.84%
ROIC/WACC0.39
Cap/Depr(3y)86.46%
Cap/Depr(5y)148.77%
Cap/Sales(3y)29.96%
Cap/Sales(5y)37.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%
EBIT growth 1Y-12.01%
EBIT growth 3Y8.03%
EBIT growth 5Y13.28%
EBIT Next Year171.97%
EBIT Next 3Y39.68%
EBIT Next 5YN/A
FCF growth 1Y-150.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.65%
OCF growth 3Y-18.09%
OCF growth 5Y-6.77%

AMERICAN HEALTHCARE REIT INC / AHR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHR.


Can you provide the valuation status for AMERICAN HEALTHCARE REIT INC?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.


What is the profitability of AHR stock?

AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 5 / 10.


What is the expected EPS growth for AMERICAN HEALTHCARE REIT INC (AHR) stock?

The Earnings per Share (EPS) of AMERICAN HEALTHCARE REIT INC (AHR) is expected to decline by -67.79% in the next year.


How sustainable is the dividend of AMERICAN HEALTHCARE REIT INC (AHR) stock?

The dividend rating of AMERICAN HEALTHCARE REIT INC (AHR) is 1 / 10 and the dividend payout ratio is -1265.55%.